[Definitive contraception with Essure device: Single institutional experience on 517 procedures]. / Anticoncepción definitiva con Essure: experiencia unicéntrica de 517 procedimientos.

OBJECTIVES: To analyse the outcomes of patients undergoing Essure sterilization in a single institution, interns of complications and technique failure. PATIENTS AND METHODS: Retrospective descriptive study of 517 patients underwent definitive contraception with Essure device in outpatient hysteroscopy office without anesthesia and controlled at 3 months with abdominal radiography, ultrasonography and hysterosalpingography in selected cases. RESULTS: The success rates of the insertion of Essure was 96.8%, similar to data reported in the literature with 3.7% of vagal reactions, as most prevalent complication. 7 (1.35%) unintended pregnancies were observed. CONCLUSIONS: Essure is a permanent birth control device, with high rate of successful insertion and a low rate of complications. Unintended pregnancies in our study are high and we must change the protocols of placement and monitoring, considering hysterosalpingography as a routine control test.

Unusual sonographic findings in a case of atypical medullary inflammatory carcinoma of the breast.

We report the case of a 35-year-old woman who complained of a rapid enlargement of a pre-existing breast mass and yellowish nipple discharge. Clinical examination revealed a firm mass measuring 15 x 10 cm and "peau d'orange" phenomenon. Sonography revealed a well-defined mass with heterogeneous echotexture and hyperechoic trabecular structures that delineated hypoechoic areas, resulting in a honeycomb pattern. The patient underwent a surgical exploration and a biopsy of the mass and of the skin. The histopathologic examination revealed an atypical medullary carcinoma with high mitotic activity.